semaglutide $150 a month in Chandler AZ OnlineSemaglutide.org GLP-1 Review 2026: Why

The primary cardiovascular end-point event occurred in 569 of the 8803 patients (6.5%) in the semaglutide group and 701 of the 8801 patients (8.0%) in the placebo group (Lincoff et al

Medical supervision matters because semaglutide affects appetite, digestion and blood sugar,r and those changes need to be monitored carefully

According to the MHRA SmPC, these include: Nausea : very common (may affect more than 1 in 10 people) Vomiting and diarrhoea : common (may affect up to 1 in 10 people) Constipation : common, potentially related to delayed gastric emptying Abdominal pain and dyspepsia : common These gastrointestinal effects generally diminish over time as the body adapts to the medication

doi: 10.1007/s00125-001-0724-2 106 RedondoMJLibmanIChengPKollmanCTosurMGalRLet al

But the authors appropriately noted limitations: the retrospective design, small sample size, and the fact that most patients were already in remission when starting therapy